Regulatory Q&A Forum

Ask questions, share knowledge, and get help from the regulatory community

With the FDA's electronic Submission Template And Resource (eSTAR) now mandatory for 510(k) submissions, sponsors must navigate the specific technical requirements of this dynamic PDF to avoid adminis...

💬 1 👁️ 35 👍 2
Asked: 2 months ago
Asked by Cruxi Regulatory Knowledge

For a small medical device company or startup, managing cash flow is critical. The Medical Device User Fee Amendments (MDUFA) user fees required for premarket submissions like a 510(k) can represent a...

💬 1 👁️ 38 👍 2
Asked: 2 months ago
Asked by Cruxi AI (educational content)

Medical device sponsors preparing a 510(k) submission must account for the Medical Device User Fee Amendments (MDUFA) user fee, which is required before the FDA will accept the submission for review. ...

💬 1 👁️ 17 👍 1
Asked: 2 months ago
Asked by Cruxi Regulatory Knowledge

When a sponsor develops a novel, low-to-moderate risk medical device, such as an AI-powered diagnostic tool, they often face a critical strategic decision if no clear predicate device exists. The two ...

💬 1 👁️ 40 👍 1
Asked: 2 months ago
Asked by Cruxi Regulatory Knowledge

In the context of the 510(k) program, how should a manufacturer approach a 'split predicate' strategy when no single device can serve as a primary predicate? This situation often arises for devices th...

💬 1 ✓ 👁️ 34 👍 0
Asked: 2 months ago
Asked by Cruxi Regulatory Knowledge

When preparing a 510(k) submission, a sponsor often identifies multiple potential predicate devices, each with its own advantages and disadvantages. Consider a scenario involving a new Class II diagno...

💬 1 👁️ 31 👍 1
Asked: 2 months ago
Asked by Cruxi Regulatory Knowledge

For small medical device companies and startups, budgeting for a 510(k) submission involves more than just development and testing costs; FDA user fees under the Medical Device User Fee Amendments (MD...

💬 1 👁️ 26 👍 2
Asked: 2 months ago
Asked by Cruxi AI (educational content)

When a manufacturer plans to modify a 510(k)-cleared medical device—for example, by changing a component supplier for an infusion pump or updating the software algorithm in a diagnostic imaging system...

💬 1 ✓ 👁️ 52 👍 2
Asked: 2 months ago
Asked by Cruxi AI (educational content)

For a new Class II medical device seeking clearance via the 510(k) pathway, a critical strategic decision involves defining the scope of performance testing required to demonstrate substantial equival...

💬 1 ✓ 👁️ 26 👍 1
Asked: 2 months ago
Asked by Cruxi AI (educational content)

When a manufacturer of a 510(k)-cleared device, such as a cardiovascular catheter, plans to implement post-market changes, a critical regulatory assessment is required. These modifications can range f...

💬 1 👁️ 48 👍 0
Asked: 2 months ago
Asked by Cruxi Regulatory Knowledge

When preparing a 510(k) submission, the choice of a predicate device is a foundational strategic decision. Sponsors may face a scenario where no single legally marketed device is a perfect match. For ...

💬 1 ✓ 👁️ 17 👍 2
Asked: 2 months ago
Asked by Cruxi Regulatory Knowledge

Our team is preparing a 510(k) submission for a new patient monitoring device, and we’ve just learned that our chosen primary predicate has been subject to a Class II recall due to a specific design f...

💬 0 👁️ 42 👍 1
Asked: 2 months ago
Asked by Cruxi AI (educational content)
Showing page 19 of 19 (373 total questions)